Suvi M Virtanen | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Suvi M Virtanen | Medicine and Dentistry | Best Researcher Award

Research Professor, Finnish Institute for Health and Welfare , Finland

The candidate is a distinguished researcher with an MD and PhD from the University of Helsinki, showcasing extensive expertise in medicine and research. Currently serving as a Research Professor at the Finnish Institute for Health and Welfare and a Professor of Epidemiology at Tampere University, the candidate has demonstrated outstanding leadership in public health and nutrition research. Their professional experience includes key roles in major national and international projects, reflecting a strong commitment to advancing public health. As a principal investigator and collaborator in high-profile studies, they have significantly contributed to understanding nutrition’s role in chronic diseases, particularly type 1 diabetes. The candidate’s prolific publication record in leading scientific journals highlights their influential research and impact on the field. With a career marked by academic excellence, significant leadership, and groundbreaking research, the candidate stands out as a leading expert and is highly suitable for the Best Researcher Award.

 

Profile:

Education

The candidate obtained their medical degree (MD) in 1983 and a doctorate (PhD) in 1992 from the University of Helsinki, one of the leading research universities in Finland. Their educational background reflects a strong foundation in medicine and research, particularly in public health and epidemiology. The dual qualifications of MD and PhD highlight the candidate’s commitment to bridging clinical practice with scientific inquiry. Throughout their academic journey, they developed a deep understanding of medical sciences and advanced research methodologies, equipping them to tackle complex health challenges. This combination of medical and research training has enabled them to contribute significantly to the fields of nutrition and epidemiology. Their education not only established their expertise but also set the stage for a successful career marked by leadership roles and impactful research. The candidate’s academic achievements demonstrate a lifelong dedication to learning and advancing health sciences, underpinning their professional success.

 

Professional Experiences 

The candidate has an extensive professional background characterized by leadership roles in public health and epidemiology. Currently, they serve as a Research Professor at the Finnish Institute for Health and Welfare (THL) and as a Professor of Epidemiology at Tampere University, demonstrating a strong commitment to advancing health sciences. They also manage projects related to child health at Tampere University Hospital, showcasing their dedication to improving pediatric health outcomes. Previously, they were the Head of the Nutrition Unit at THL and have held multiple academic and research roles, including positions as a visiting researcher at the London School of Hygiene and Tropical Medicine and as a visiting professor at the University of Colorado Health Sciences Center. Their international experience, combined with years of service in various national health councils and academic positions, highlights their multidisciplinary expertise and ability to lead significant research initiatives in nutrition, epidemiology, and public health.

 

Research Interests

The candidate’s research interests focus on the intersection of nutrition, epidemiology, and public health, with a strong emphasis on understanding the role of diet in the prevention and development of chronic diseases, particularly type 1 diabetes and autoimmune conditions. They have led numerous large-scale, longitudinal studies that explore how dietary patterns, early nutrition, and environmental factors influence disease risk from childhood through adulthood. Their work aims to identify critical dietary determinants of health, unraveling complex interactions between genetics, immune response, and lifestyle factors. The candidate’s research also extends to nutritional epidemiology, investigating the impact of maternal and infant nutrition on long-term health outcomes. Through participation in international consortia and collaborations, they have contributed significantly to advancing scientific knowledge on immune-mediated diseases and dietary interventions. Their ultimate goal is to inform public health policies and develop evidence-based dietary guidelines that promote disease prevention and enhance the quality of life across populations.

 

Research Skills

The candidate demonstrates exceptional research skills characterized by a robust blend of scientific rigor, leadership, and multidisciplinary collaboration. As a Research Professor at the Finnish Institute for Health and Welfare, they lead innovative studies that address critical public health challenges, particularly in the fields of nutrition and epidemiology. Their expertise is further showcased by their involvement in international projects, such as the EU-consortium Zero Hidden Hunger and national nutrition monitoring initiatives, where they serve as a principal investigator. The candidate’s prolific publication record in high-impact journals underscores their ability to produce meaningful, data-driven insights that influence the scientific community and public health policies. They have consistently contributed to groundbreaking research on the relationship between diet and chronic diseases, including type 1 diabetes, through methodologically sound studies. Their ability to manage complex research projects and guide multidisciplinary teams highlights their outstanding research skills and commitment to advancing scientific knowledge for societal benefit.

 

Award And Recognition 

The candidate’s outstanding contributions to nutrition and epidemiological research have earned them significant recognition within the scientific community. As a Research Professor at the Finnish Institute for Health and Welfare and a Professor of Epidemiology at Tampere University, they have led pioneering studies that address critical public health issues, including dietary impacts on autoimmune diseases. Their work has been published extensively in high-impact journals, and they are regularly invited to contribute to key international research collaborations, such as the EU-consortium Zero Hidden Hunger. They have played pivotal roles as principal investigator and committee member in numerous landmark studies, demonstrating exceptional leadership and expertise. The candidate’s dedication to advancing the fields of nutrition and public health has not only influenced policy but also improved health outcomes globally. Their achievements reflect a distinguished career marked by impactful research, academic leadership, and a commitment to enhancing the well-being of populations worldwide.

 

Conclusion

Based on the candidate’s comprehensive qualifications and achievements, they are highly deserving of the Best Researcher Award. With an extensive educational background that includes an MD and PhD from the University of Helsinki, the candidate has built a robust foundation in medical and research expertise. Their professional experience spans multiple high-impact roles, including Research Professor at the Finnish Institute for Health and Welfare and Professor of Epidemiology at Tampere University. They have demonstrated exceptional leadership in numerous significant research projects, such as the EU-consortium Zero Hidden Hunger and national nutrition monitoring programs. The candidate’s prolific publication record in top-tier journals, particularly on diet and autoimmune diseases like type 1 diabetes, highlights their contribution to advancing public health knowledge. Their multidisciplinary expertise, international collaborations, and commitment to impactful research establish them as a leading figure in their field, making them an outstanding candidate for this award.

 

Publication Top Notes

  1. Title: Early-pregnancy BMI, maternal gestational weight gain, and asthma and allergic diseases in children
    Authors: Ojwang’, V., Nwaru, B.I., Hanna-Mari, T., … Knip, M., Virtanen, S.M.
    Journal: Pediatric Allergy and Immunology
    Year: 2024
    Citations: 0
  2. Title: High Concentrations of Immunoglobulin G Against Cow Milk Proteins and Frequency of Cow Milk Consumption Are Associated With the Development of Islet Autoimmunity and Type 1 Diabetes—The Trial to Reduce Insulin-dependent Diabetes Mellitus (IDDM) in the Genetically at Risk (TRIGR) Study
    Authors: Niinistö, S., Cuthbertson, D., Miettinen, M.E., … Savilahti, E., Virtanen, S.M.
    Journal: Journal of Nutrition
    Year: 2024
    Citations: 0
  3. Title: Maternal gluten, cereal, and dietary fiber intake during pregnancy and lactation and the risk of islet autoimmunity and type 1 diabetes in the child
    Authors: Hakola, L., Lund-Blix, N.A., Takkinen, H.-M., … Aki, S., Marja, R.
    Journal: Clinical Nutrition ESPEN
    Year: 2024
    Citations: 0
  4. Title: Gut Inflammation Markers, Diet, and Risk of Islet Autoimmunity in Finnish Children – A Nested Case-Control Study
    Authors: Salo, T.E., Hakola, L., Niinistö, S., … Knip, M., Virtanen, S.M.
    Journal: Journal of Nutrition
    Year: 2024
    Citations: 0
  5. Title: Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk
    Authors: Bhosale, S.D., Moulder, R., Suomi, T., … Knip, M., Lahesmaa, R.
    Journal: iScience
    Year: 2024
    Citations: 0
  6. Title: Intake of B vitamins and the risk of developing islet autoimmunity and type 1 diabetes in the TEDDY study
    Authors: Hakola, L., Mramba, L.K., Uusitalo, U., … Norris, J.M., Virtanen, S.M.
    Journal: European Journal of Nutrition
    Year: 2024
    Citations: 1
  7. Title: Detecting potential outliers in longitudinal data with time-dependent covariates
    Authors: Mramba, L.K., Liu, X., Lynch, K.F., … Uusitalo, U.M., Krischer, J.P.
    Journal: European Journal of Clinical Nutrition
    Year: 2024
    Citations: 3
  8. Title: Fruit, berry, and vegetable consumption and the risk of islet autoimmunity and type 1 diabetes in children—the Type 1 Diabetes Prediction and Prevention birth cohort study
    Authors: Mattila, M., Takkinen, H.-M., Peltonen, E.J., … Knip, M., Virtanen, S.M.
    Journal: American Journal of Clinical Nutrition
    Year: 2024
    Citations: 1
  9. Title: How prices and income influence global patterns in saturated fat intake by age, sex and world region: a cross-sectional analysis of 160 countries
    Authors: Ahles, A., Muhammad, A., Yenerall, J.N., … Siamusantu, W., Brown, K.
    Journal: BMJ Open
    Year: 2024
    Citations: 0
  10. Title: Periodic mobile application (eMOM) with self-tracking of glucose and lifestyle improves treatment of diet-controlled gestational diabetes without human guidance: a randomized controlled trial
    Authors: Kytö, M., Hotta, S., Niinistö, S., … Heihonen, S., Koivusalo, S.B.
    Journal: American Journal of Obstetrics and Gynecology
    Year: 2024
    Citations: 0

 

Sampatha Goonewardena | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Sampatha Goonewardena | Medicine and Dentistry | Best Researcher Award

Professor in Community Medicine, University of Sri Jayewardenepura , Sri Lanka

Christine Sampatha Evangeline Goonewardena, a distinguished Professor of Community Medicine at the University of Sri Jayewardenepura, is an exemplary candidate for the Best Researcher Award. With multiple degrees, including an MBBS, MD, and MSc in Community Medicine, she has made significant contributions to public health, particularly in maternal and child health. Her extensive publications address critical issues such as maternal mortality and health-seeking behaviors, influencing both policy and practice in Sri Lanka’s healthcare system. Dr. Goonewardena’s research emphasizes culturally sensitive approaches, enhancing health education and care practices in vulnerable communities. Through her initiatives, she has improved postnatal care and women’s health awareness, making a tangible impact on public health outcomes. Her dedication to advancing knowledge and fostering meaningful changes in healthcare practices underscores her leadership in the field, making her a deserving recipient of this prestigious award.

Profile:

 

Education

Dr. Christine Sampatha Evangeline Goonewardena has a comprehensive educational background that forms the cornerstone of her distinguished career in community medicine. She obtained her MBBS from North Colombo Medical College in 1990, followed by an MSc in Community Medicine from the Post Graduate Institute of Medicine, University of Colombo in 1994. She further advanced her expertise by earning an MD in Community Medicine, where she conducted an extensive thesis on intrapartum and postpartum care quality in Sri Lanka. Dr. Goonewardena also completed specialized training at the Liverpool School of Tropical Medicine in the UK, obtaining a Diploma in Reproductive Health and completing MD Part III training in 2003. These academic accomplishments, combined with her continuous professional development, have equipped her with a deep understanding of public health challenges, particularly in maternal and child health. Her education has been pivotal in driving her research and contributions to improving healthcare standards in Sri Lanka.

Professional Experiences

Christine Sampatha Evangeline Goonewardena has a distinguished career in community medicine, spanning over three decades. Since June 2017, she has served as a Professor of Community Medicine at the Faculty of Medical Sciences, University of Sri Jayewardenepura, where she also held the position of Head of the Department. Prior to this, she was a Senior Lecturer and played a key role in shaping the curriculum and research initiatives in community medicine. Dr. Goonewardena has also contributed to postgraduate education as a visiting lecturer at the Post Graduate Institute of Medicine, University of Colombo. Her experience includes serving as a Specialist Community Physician and working in maternal and child health, where she implemented programs to improve healthcare delivery. Dr. Goonewardena’s extensive background in teaching, research, and community engagement underscores her commitment to advancing public health and training the next generation of medical professionals.

 

Research skills

Christine Sampatha Evangeline Goonewardena possesses exceptional research skills that have significantly contributed to the field of Community Medicine. Her extensive experience in designing and conducting studies is evidenced by her numerous peer-reviewed publications addressing critical public health issues, including maternal and child health. Dr. Goonewardena’s ability to synthesize complex data and translate findings into actionable health policies demonstrates her analytical prowess. Her research methodology is rigorous, employing both qualitative and quantitative approaches to ensure comprehensive insights into community health challenges. Additionally, her expertise in statistical analysis and data interpretation enables her to effectively evaluate health programs and interventions. Through her collaborative efforts with local healthcare institutions, Dr. Goonewardena has fostered impactful partnerships that enhance the applicability of her research. Overall, her research skills not only advance academic knowledge but also drive meaningful improvements in health outcomes for underserved populations.

 

Awards And Recoginition

Christine Sampatha Evangeline Goonewardena, Professor of Community Medicine at the University of Sri Jayewardenepura, has made significant contributions to public health research, particularly in maternal and child health. Her impressive academic credentials include an MBBS, MD, and MSc in Community Medicine. Dr. Goonewardena’s research has been published in numerous peer-reviewed journals, focusing on critical issues such as breastfeeding practices and the quality of postnatal care, thereby influencing healthcare policies in Sri Lanka. Her dedication to improving community health outcomes is evident through her initiatives and community engagement. Dr. Goonewardena’s commitment to excellence has earned her recognition in the field, making her a deserving candidate for the Best Researcher Award. Through her work, she continues to inspire future generations of healthcare professionals and researchers, fostering a healthier society.

 

Conclusion

In conclusion, Christine Sampatha Evangeline Goonewardena stands out as an exceptional candidate for the Best Researcher Award. Her extensive research contributions, particularly in maternal and child health, reflect a deep commitment to improving public health in Sri Lanka. Through her numerous peer-reviewed publications, she has addressed critical health issues, providing valuable insights that have influenced both policy and practice. Dr. Goonewardena’s ability to translate research findings into actionable community health initiatives demonstrates her dedication to enhancing healthcare quality. Moreover, her leadership roles within academia and her focus on culturally sensitive health practices highlight her influence as a mentor and advocate for health equity. By recognizing her achievements, the Best Researcher Award would honor not only her individual contributions but also the positive impact she has made on the health and well-being of countless individuals and families in her community.

 

Publication Top Notes

  • Knowledge, attitudes, and practices related to known risk factors and screening for cervical cancer in adult females in estates in Kahawatte, Sri Lanka
    Authors: A.K.P.J. Arumapperuma; C.S.E. Goonewardena
    Year: 2016
    Citation: European Journal of Cancer, DOI: 10.1016/j.ejca.2016.03.017
  • Public Health Midwives’ role in health education regarding vaginal discharge: A Cross Sectional Descriptive Study
    Authors: IMPS Ilankoon; CSE Goonewardena
    Year: 2016
    Citation: IJSRM, DOI: 10.18535/ijsrm/v4i6.12
  • Factors associated with growth faltering in Sri Lankan infants: A case-control study in selected child welfare clinics in Sri Lanka
    Authors: Nevinda De Silva; Kasun Wijerathna; Sachini Kahatapitiya; Prabath Silva; Isuranga Herath; Ruwanthi Perera; Sampatha Goonewardena
    Year: 2015
    Citation: Journal of the Postgraduate Institute of Medicine, DOI: 10.4038/jpgim.8074
  • Editorial 19(1)
    Authors: Sampatha Goonewardena; Shamini Prathapan
    Year: 2014
    Citation: Journal of the College of Community Physicians of Sri Lanka, DOI: 10.4038/jccpsl.v19i1.7619
  • Editorial Vol.19(2)
    Authors: Sampatha Goonewardena; Shamini Prathapan
    Year: 2014
    Citation: Journal of the College of Community Physicians of Sri Lanka, DOI: 10.4038/jccpsl.v19i2.7587
  • Editorial Vol.18(1)
    Authors: Sampath Goonewardena; Shamini Prathapan
    Year: 2013
    Citation: Journal of the College of Community Physicians of Sri Lanka, DOI: 10.4038/jccpsl.v18i1.6074
  • Editorial Vol.17(1)
    Authors: Sampatha Goonewardena; Shamini Prathapan
    Year: 2012
    Citation: Journal of the College of Community Physicians of Sri Lanka, DOI: 10.4038/jccpsl.v17i1.4928
  • A stark glimpse of challenges for tomorrow
    Authors: Sampatha Goonewardena; Shamini Prathapan
    Year: 2012
    Citation: Journal of the College of Community Physicians of Sri Lanka, DOI: 10.4038/jccpsl.v16i2.4574
  • Cancer: A hidden burden
    Authors: Sampatha Goonewardena
    Year: 2011
    Citation: Journal of the College of Community Physicians of Sri Lanka, DOI: 10.4038/jccpsl.v16i1.3871
  • Delay among women reporting symptoms of breast cancer
    Authors: PBVR Kumari; CSE Goonewardena
    Year: 2011
    Citation: Journal of the College of Community Physicians of Sri Lanka, DOI: 10.4038/jccpsl.v16i1.3867
  • Editorial Vol.14(1)
    Authors: Sampatha Goonewardena
    Year: 2011
    Citation: Journal of the College of Community Physicians of Sri Lanka, DOI: 10.4038/jccpsl.v14i1.2940

 

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79

 

 

Royston Liew | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. Royston Liew | Medicine and Dentistry | Best Researcher Award

Student at Duke-NUS Medical School, Singapore

Dr. Liew Yew Meng Royston is an emerging researcher with a background in Chemical and Biomolecular Engineering, focusing on the molecular mechanisms underlying Hepatocellular Carcinoma (HCC), particularly in None-B-None-C HCC patients. His research integrates engineering principles with biological sciences, offering a novel approach to understanding complex disease pathways, such as bile acid homeostasis. Dr. Royston is proactive in his research endeavors, having initiated wet-lab experiments months in advance under the guidance of Professor Pierce Chow. His work has led to significant findings in the role of post-translational modifications in liver-gut homeostasis. In addition to his research, Dr. Royston has been recognized for his innovation with multiple patents and awards, including the National Runner-Up in the James Dyson Award for his work in vertical farming. His interdisciplinary approach and commitment to advancing medical research make him a promising figure in the field of oncology and biomedical engineering.

Profile

Education

Dr. Liew Yew Meng Royston holds a Bachelor of Engineering (Honours) in Chemical and Biomolecular Engineering from Nanyang Technological University, Singapore, where he studied from 2018 to 2022. His academic training provided a strong foundation in engineering principles, which he has effectively applied to his research in the biomedical field. During his undergraduate studies, Dr. Royston demonstrated a keen interest in integrating engineering with biological systems, laying the groundwork for his current research in Hepatocellular Carcinoma (HCC). His educational journey was marked by academic excellence, earning him a place on the Dean’s List for the 2018/2019 academic year. The interdisciplinary nature of his education has equipped Dr. Royston with the skills to approach complex biological problems with precision and innovation, making significant contributions to his field. His commitment to academic and research excellence continues to drive his pursuit of advanced knowledge in medicine and biomedical engineering.

Professional Experience

Dr. Liew Yew Meng Royston has demonstrated considerable professional experience in both research and innovation. He is currently focused on Hepatocellular Carcinoma (HCC) research, specifically None-B-None-C HCC (NBNC HCC), where he applies his background in chemical and biomolecular engineering to investigate bile acid homeostasis and its implications for liver function. Before beginning his Duke-NUS Phase 3 Scholarly Research Project, Dr. Royston proactively engaged in preliminary research with Professor Pierce Chow, resulting in significant novel findings. His research approach integrates engineering principles with biological systems, employing techniques such as molecular pathway modeling and process optimization. Beyond his research, Dr. Royston has made notable contributions to the field of vertical farming, with a patent for a modular hydroponic system and recognition through awards like the James Dyson Award and the APAC CEO of the Year Awards. His expertise reflects a blend of scientific rigor and innovative problem-solving.

Research Interest

Dr. Liew Yew Meng Royston’s research interest centers on elucidating the molecular and cellular mechanisms underlying Hepatocellular Carcinoma (HCC), specifically focusing on None-B-None-C Hepatocellular Carcinoma (NBNC HCC). His work involves investigating the dysregulation of bile acid homeostasis pathways and their impact on liver function in NBNC HCC patients. By applying principles from Chemical and Biomolecular Engineering, Dr. Royston integrates metabolomic, microbiomic, and transcriptomic data to identify critical alterations in disease mechanisms. His research explores the role of post-translational modifications, particularly acetylation of the FXR protein, in influencing bile acid production and liver-gut homeostasis. Additionally, he investigates the effects of highly processed diets on the microbiome and their subsequent role in HCC development. Dr. Royston’s interdisciplinary approach aims to deepen understanding of HCC and develop innovative strategies for its treatment, blending engineering precision with advanced biological research.

Research Skills

Dr. Liew Yew Meng Royston possesses a diverse skill set tailored to his research in Hepatocellular Carcinoma (HCC). His skills include advanced techniques in metabolomics, microbiomics, and transcriptomics, which are essential for analyzing complex biological data. Dr. Royston is proficient in molecular pathway modeling and process optimization, applying engineering principles to biological systems. His expertise extends to wet-lab experimentation, including the study of post-translational modifications of proteins and their effects on gene transcription. Additionally, Dr. Royston employs systems-level approaches to integrate various biological and biochemical data, enhancing the precision and depth of his research. His proactive approach to research, demonstrated by initiating preliminary work and securing foundational results, further highlights his commitment and technical capabilities in addressing complex biomedical challenges.

Award and Recognition

Dr. Liew Yew Meng Royston has received significant recognition for his contributions to research and innovation. Notably, he was awarded the National Runner-Up position in the James Dyson Award in 2022 for his work on vertical farming, highlighting his innovative approach to urban agriculture. His invention of a modular hydroponic farming apparatus was patented internationally, underscoring his inventive capabilities. In addition to these achievements, Dr. Royston received the APAC CEO of the Year Awards for Most Innovative Agribusiness CEO in 2022, reflecting his impact on the agribusiness sector. His research efforts have also been supported by several grants, including the SSG Tech POC Grant of $250,000 and the SSG Founder’s Startup Grant of $50,000. Dr. Royston’s academic excellence was recognized through his inclusion on the Dean’s List at Nanyang Technological University for the academic year 2018/2019, further attesting to his dedication and outstanding performance in his field.

Conclusion

Liew Yew Meng Royston demonstrates significant potential as a researcher with a strong interdisciplinary approach and innovative mindset. His proactive research efforts, combined with his engineering background, position him as a promising candidate for the Best Researcher Award. However, enhancing his publication record and securing research grants could further solidify his standing in the research community.

Publication Top Notes

Diagnostic laparoscopy for pre-operative selection of patients with known peritoneal carcinomatosis for CRS-HIPEC: A systematic review and meta-analysis

  • Authors: Ang, A.J.Y., Liew, R.Y.M., Aw, V.Z.J., Chia, C.S., Shannon, N.B.
  • Year: 2024
  • Journal: European Journal of Surgical Oncology
  • Volume: 50
  • Issue: 11
  • Article Number: 108623

 

Marine Gogia | Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Marine Gogia | Medicine | Best Researcher Award

Program Director at Georgian Harm Reduction Network, Georgia.

Dr. Marine Gogia is a distinguished Public Health Specialist and Patient Advocate with extensive experience in harm reduction and epidemiology. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, following her Master’s in Public Health from the University of Georgia. Dr. Gogia’s career highlights include her role as Programs Director at the Georgian Harm Reduction Network, where she manages significant projects like the Global Fund initiative targeting HIV/AIDS prevention and harm reduction. Her research encompasses HIV self-testing, hepatitis C treatment, and risk behavior assessments among marginalized groups. Dr. Gogia’s contributions extend to her leadership roles with the European AIDS Treatment Group and various international health organizations. She has been recognized for her impactful research and advocacy, which include numerous publications and presentations at global conferences.

Profile
Education

Dr. Marine Gogia is a highly educated public health specialist with a strong academic background. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, USA (2022-2025). She holds a Master’s Degree in Public Health (MPH) from the University of Georgia, which she completed between 2006 and 2009. Dr. Gogia’s foundational education was at Tbilisi State Medical University, where she studied Preventive Medicine (1996-2002). Her commitment to continuing education is evident from her participation in specialized courses, including the European Patients Academy (EUPATI) Expert Patients Course (2017-2018) and the EATG Training Academy’s STEP-UP program (2014-2015). This extensive educational background has equipped her with a robust understanding of public health, epidemiology, and the skills necessary to address complex health challenges effectively.

Professional Experience

Dr. Marine Gogia, a distinguished Public Health Specialist and Patient Advocate, has amassed extensive experience in public health, harm reduction, and infectious disease control. Currently a Programs Director at the Georgian Harm Reduction Network (GHRN), she leads critical projects such as the Global Fund initiative to prevent HIV/AIDS and minimize drug-related harm. Her role encompasses both management and research, with notable studies on HIV self-testing and Hepatitis C elimination. Dr. Gogia has also contributed as a Co-chair at the European AIDS Treatment Group (EATG), where she provides technical expertise and strategic direction. Her prior roles include consulting for WHO and the Global Fund, and serving as a Program Coordinator at Curatio International Foundation. Her work reflects a commitment to improving health outcomes and advocating for marginalized communities through rigorous research and strategic program implementation.

Research Interest

Dr. Marine Gogia’s research interests center around public health, with a particular focus on HIV/AIDS, harm reduction, and epidemiology. She is dedicated to advancing strategies for combating HIV and hepatitis C, especially among vulnerable populations such as people who inject drugs (PWID) and marginalized groups. Her work involves evaluating and improving harm reduction programs, assessing risky behaviors, and enhancing access to healthcare services through innovative research methodologies like simplified bio-behavioral surveillance surveys. Dr. Gogia is also actively involved in policy advocacy and capacity building, contributing to global health guidelines and strategies. Her research aims to bridge gaps in healthcare access and improve the effectiveness of public health interventions, with significant contributions to regional and international efforts in infectious disease control and prevention.

Research Skills

Dr. Marine Gogia possesses exceptional research skills demonstrated through her extensive experience in public health and epidemiology. Her expertise includes conducting bio-behavioral surveillance surveys, operational research, and evaluating HIV and hepatitis C testing and treatment programs. Dr. Gogia excels in designing and implementing research methodologies, such as the BSS-Lite survey, to assess risky behaviors among people who inject drugs (PWIDs). She is adept at analyzing data related to HIV self-testing acceptability and identifying barriers to HCV program enrollment. Her research skills are further evident in her contributions to studies on legal and regulatory barriers, and her ability to synthesize complex information into actionable insights for policy-making. Dr. Gogia’s proficiency extends to training and consultancy, where she effectively translates research findings into practical solutions for public health challenges. Her work consistently reflects a high level of analytical rigor and a commitment to advancing public health outcomes.

Awards and Recognition

Maryam has received several certificates of participation and training, including the Training of Trainers certificates, a peer reviewer course, and various certificates in statistical analysis and genetic research. These accolades demonstrate her commitment to continuous learning and professional development.

Conclusion

Maryam Qasim is a promising candidate for the Best Researcher Award due to her significant contributions to antimicrobial resistance research and molecular genetics. Her work, although primarily regional, has the potential to address broader health issues through applied research and collaborative efforts. Her academic background and continued professional development through various certifications further strengthen her candidacy.

Publications Top Notes

  1. Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024
    • Authors: Tohme, R.A., Shadaker, S., Adamia, E., Schumacher, I.T., Gabunia, T.
    • Year: 2024
  2. Piloting a Simplified Bio-Behavioural Survey Methodology, the BBS-Lite, Among People Who Inject Drugs in Georgia
    • Authors: Gogia, M., Ruadze, E., Kasrashvili, T., Khonelidze, I., Stvilia, K.
    • Year: 2024
  3. Recommendations for Defining Preventable HIV-Related Mortality for Public Health Monitoring in the Era of Getting to Zero: An Expert Consensus
    • Authors: Croxford, S.E., Martin, V., Lucas, S.B., Waters, L.J., Sullivan, A.K.
    • Year: 2023
    • Citations: 1
  4. Barriers of Linkage to HCV Viremia Testing Among People Who Inject Drugs in Georgia
    • Authors: Butsashvili, M., Abzianidze, T., Kamkamidze, G., Nasrullah, M., Averhoff, F.
    • Year: 2022
    • Citations: 2
  5. Hidden Populations: Risk Behaviours in Drug-Using Populations in the Republic of Georgia Through Subsequent Peer-Driven Interventions
    • Authors: Lawlor, C., Gogia, M., Kirtadze, I., Jikia, G., Zurashvili, T.
    • Year: 2021
    • Citations: 1
  6. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic
    • Authors: Farhoudian, A., Radfar, S.R., Ardabili, H.M., Yitayih, Y., Zhao, M.
    • Year: 2021
    • Citations: 44
  7. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
    • Authors: Radfar, S.R., De Jong, C.A.J., Farhoudian, A., Zhao, M., Zonoozi, A.K.
    • Year: 2021
    • Citations: 53
  8. Integration of Hepatitis C Treatment at Harm Reduction Centers in Georgia—Findings from a Patient Satisfaction Survey
    • Authors: Butsashvili, M., Kamkamidze, G., Kajaia, M., Japaridze, M., Averhoff, F.
    • Year: 2020
    • Citations: 9
  9. Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
    • Authors: Stvilia, K., Spradling, P.R., Asatiani, A., Averhoff, F., Nasrullah, M.
    • Year: 2019
    • Citations: 17
  10. Hidden Populations: Discovering the Differences Between the Known and the Unknown Drug-Using Populations in the Republic of Georgia
    • Authors: Gogia, M., Lawlor, C., Shengelia, N., Stvilia, K., Raymond, H.F.
    • Year: 2019
    • Citations: 1

 

Mariano Marrodan | Medicine and Dentistry | Young Scientist Award

Posted on by ScienceFather

Dr. Mariano Marrodan | Medicine and Dentistry | Young Scientist Award

Surgery Resident and Fleni, Argentina.

Dr. Mariano Marrodan, MD, MSc, is a distinguished neurologist based in Buenos Aires, Argentina, with a robust background in neuroimmunology and multiple sclerosis. Currently, he serves as a Staff Neurologist at Fleni and Hospital Zonal General de Agudos Domingo Mercante. Dr. Marrodan holds a Master’s in Neuroimmunology from Universidad Autónoma de Barcelona and has completed notable fellowships at Cemcat and FLENI. His clinical research focuses on multiple sclerosis, autoimmune encephalitis, and neuroimmunology, with significant contributions to the understanding of Susac Syndrome and neuromyelitis optica spectrum disorders. He has published extensively in prestigious journals and is actively involved in mentoring and teaching, including directing neuroimmunology courses and coordinating virtual neuroimmunology rounds. Dr. Marrodan’s work, recognized through various awards, showcases his impact on advancing neurological research and improving patient care in Argentina and beyond.

Profile

Education

Dr. Mariano Marrodan’s educational background is distinguished by rigorous training and specialization in neurology and neuroimmunology. He earned his medical degree from Austral University in Buenos Aires, Argentina, graduating with honors in 2014. Following this, Dr. Marrodan completed his Neurology Residency at the Institute for Neurological Research Raul Carrea – FLENI from 2014 to 2018. His pursuit of specialized knowledge led him to a Clinical Fellowship in Multiple Sclerosis and Neuroimmunology at FLENI, which he completed in 2021. To further deepen his expertise, he pursued a Master’s in Neuroimmunology at the Universidad Autónoma de Barcelona (UAB), Spain, from 2022 to 2023. Additionally, he undertook a Multiple Sclerosis Research Fellowship at the Centre d’Esclerosi Múltiple de Catalunya (Cemcat) in Barcelona during the first half of 2023, augmenting his skills in advanced neuroimmunological research.

Professional Experience

Dr. Mariano Marrodan is a distinguished neurologist with extensive professional experience in both clinical and academic settings. Currently, he serves as a Staff Neurologist at Fleni in Buenos Aires, where he is involved in general neurology and the division of Multiple Sclerosis and Neuroimmunology. His role at Fleni began in June 2021 and includes contributions to inpatient services and specialized neuroimmunology care. Additionally, Dr. Marrodan works at Hospital Zonal General de Agudos Domingo Mercante and has held various roles at Fleni, including Junior Attending and Emergency Department Neurologist. His prior experience includes serving as a Staff Neurologist at the neurological rehabilitation center “La Horqueta” and as Neurology Chief Resident at FLENI. Dr. Marrodan’s background reflects a strong commitment to advancing neurology through clinical practice, research, and education.

Research Interests

Dr. Mariano Marrodan’s research focuses on advancing our understanding of neuroimmunological and neurodegenerative diseases, particularly Multiple Sclerosis (MS) and related conditions. His work emphasizes the pathophysiology, diagnostic strategies, and treatment outcomes of MS and neuromyelitis optica spectrum disorders (NMOSD). Dr. Marrodan is particularly interested in exploring the impact of novel therapeutic approaches and assessing their efficacy in real-world settings. His research involves extensive clinical and observational studies, such as evaluating the effects of oral Cladribine on MRI lesions in MS patients and developing a Latin-American database for Susac Syndrome. He is also engaged in the International MS Microbiome Study and the Argentinean Multiple Sclerosis Registry, which aim to deepen the understanding of disease mechanisms and treatment responses. Through his innovative research, Dr. Marrodan seeks to improve patient care and contribute to the global knowledge base on neuroimmunological disorders.

Research Skills

Dr. Mariano Marrodan exhibits exceptional research skills across multiple dimensions of neurology. His expertise spans clinical and basic research, with a notable focus on multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), and autoimmune encephalitis. Dr. Marrodan excels in designing and conducting observational and interventional studies, such as his principal investigator role in studies on oral Cladribine and Susac Syndrome. His proficiency extends to statistical analysis and study design, evidenced by his involvement in large-scale registries and multicentric collaborations. Dr. Marrodan’s adeptness in using advanced diagnostic tools, including MRI and immunological assessments, complements his strong publication record in high-impact journals. His leadership in coordinating neuroimmunology courses and mentoring junior researchers further underscores his commitment to advancing knowledge and fostering scientific growth. Dr. Marrodan’s multifaceted research skills make him a distinguished contributor to the field of neurology.

Awards and Recognition 🏆

Dr. Marrodan has received recognition through his roles in prestigious research projects and his contributions to significant publications. His continued involvement in high-profile academic and clinical roles indicates a respected position within his field.

Conclusion 🏅

Dr. Mariano Marrodan’s extensive research contributions, collaborative efforts, and applied clinical research make him a compelling candidate for the Best Researcher Award. His work not only advances the field of neurology but also impacts clinical practice and patient outcomes on a regional and global scale.

Publications Top Notes

  • Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)
    • Authors: Carnero Contentti, E., Lopez, P.A., Patrucco, L., Alonso Serena, M., Rojas, J.I.
    • Year: 2024
  • Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study
    • Authors: Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Caride, A., Rojas, J.I.
    • Year: 2024
  • Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings
    • Authors: Pestchanker, C., Bertado Cortez, B., Lana Peixoto, M.A., Lopez, P., Carnero Contentti, E.
    • Year: 2024
  • Selection of disease modifying therapies in multiple sclerosis based on patient’s age and disease activity: Data from a nationwide registry
    • Authors: Piedrabuena, M.A., Correale, J., Fiol, M., Martinez, C.M., Ysrraelit, M.C.
    • Year: 2024
  • Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients
    • Authors: Camerlingo, S., Rubinstein, F., Celia Ysrraelit, M., Silva, B.A., Alonso, R.
    • Year: 2024
    • Citations: 1
  • Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina
    • Authors: Carnero Contentti, E., López, P.A., Pappolla, A., Alonso Serena, M., Rojas, J.I.
    • Year: 2024
    • Citations: 1
  • Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis
    • Authors: Marrodan, M., Calandri, I.L., Bocancea, D.I., Fiol, M.P., Correale, J.
    • Year: 2024
  • Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry
    • Authors: Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Paul, F., Rojas, J.I.
    • Year: 2023
    • Citations: 4
  • Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome
    • Authors: Plantone, D., Sabatelli, E., Locci, S., De Stefano, N., Iorio, R.
    • Year: 2023
    • Citations: 2
  • Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting
    • Authors: Carnero Contentti, E., Lopez, P.A., Tkachuk, V., Paul, F., Rojas, J.I.
    • Year: 2023
    • Citations: 3

 

Dr. Chaima Jemai | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Chaima Jemai | Medicine and Dentistry | Best Researcher Award

Doctorate at National Institute of Nutrition of Tunis (Department C), Tunisia.

Dr. Jemai Chaima is a distinguished researcher with a Doctorate in Medicine awarded with the highest honors in October 2019. Her academic journey includes supplementary certifications in diabetic foot management and thyroidology, showcasing her commitment to specialized medical research. She has excelled in her field by successfully completing the final specialty competition in Nutrition and Nutritional Diseases in September 2020 and the Hospital-University Assistant competition in October 2020. Dr. Chaima’s research focuses on critical areas within nutrition, reflecting her expertise and dedication to advancing healthcare. Her qualifications and achievements highlight her significant contributions to medical research and clinical practice. With a deep understanding of the impact of nutrition on health, Dr. Chaima stands out as a leading figure in her field, making her an ideal candidate for the Research for Excellence in Research award. Her work promises to enhance patient outcomes and drive advancements in medical science.

Profile

Education🎓

Dr. Jemai Chaima’s educational background reflects a strong commitment to advancing her expertise in medicine. She earned her Doctorate d’État in Medicine on October 24, 2019, with the distinction of “très honorable avec félicitations du jury,” highlighting her exceptional research and academic performance. In addition to her doctoral degree, Dr. Chaima pursued supplementary certificates to further enhance her specialization. She completed a Certificate in Diabetic Foot Management from the Faculty of Medicine of Sousse in 2018/2019 and another in Thyroidology from the Faculty of Medicine of Tunis in 2021. These advanced studies underscore her dedication to expanding her knowledge in critical areas of medicine. Furthermore, Dr. Chaima excelled in the final specialty competition for Nutrition and Nutritional Diseases in September 2020 and the Hospital-University Assistant competition in October 2020, showcasing her advanced skills and readiness to contribute significantly to her field.

Professional Experience 🏢

Dr. Jemai Chaima brings a wealth of expertise in the field of medicine, with a specialized focus on Nutrition and Nutritional Diseases. Since earning her Doctorate in Medicine in October 2019, she has demonstrated remarkable dedication to her field. Her professional journey includes the completion of significant supplementary certificates, such as diabetic foot management and thyroidology, which highlight her commitment to advancing her knowledge and skills. In September 2020, she excelled in the final specialty competition, further solidifying her specialization in Nutrition and Nutritional Diseases. The following month, she succeeded in the Hospital-University Assistant competition, reflecting her readiness to contribute to both clinical practice and academic research. Dr. Chaima’s extensive training and competitive achievements position her as a leading expert, dedicated to addressing critical health issues through her research and clinical practice.

Environmental Health

Dr. Jemai Chaima’s contributions to environmental health are deeply integrated with her expertise in Nutrition and Nutritional Diseases. Her research explores the intersection of diet and environmental factors, focusing on how nutritional choices and environmental conditions impact overall health. By examining the effects of environmental pollutants and dietary habits on chronic diseases, Dr. Chaima provides valuable insights into how these factors contribute to public health issues. Her work is particularly relevant in understanding how environmental conditions exacerbate nutritional deficiencies and contribute to various health conditions. Through her specialized research and clinical practice, she aims to develop strategies to mitigate these impacts, ultimately improving community health outcomes. Dr. Chaima’s commitment to addressing environmental health issues highlights her dedication to enhancing both individual and public health through a comprehensive approach that combines environmental and nutritional science.

Research Interests 🔬

Dr. Jemai Chaima’s research interests are centered on the intersection of nutrition and medical sciences, particularly focusing on the management and prevention of nutrition-related diseases. Her expertise encompasses diabetic foot management, where she explores innovative approaches to treat and prevent complications associated with diabetes. Additionally, she has a strong interest in thyroidology, investigating the impact of thyroid disorders on nutritional health and overall well-being. Dr. Chaima’s work aims to integrate advanced nutritional strategies into clinical practice to enhance patient outcomes and address prevalent health issues. Her research is driven by a commitment to advancing knowledge in the field of nutrition and its role in managing chronic diseases, ultimately contributing to improved healthcare solutions and patient care. Through her specialized studies, Dr. Chaima seeks to bridge gaps between nutritional science and clinical application, fostering advancements that benefit both individual patients and the broader medical community.

Award and Honors

Dr. Jemai Chaima has garnered notable recognition and honors throughout her distinguished medical career. She earned her Doctorate in Medicine with the highest distinction (“très honorable avec félicitations du jury”) in October 2019, reflecting her outstanding research and academic excellence. Her commitment to advancing her expertise is further demonstrated by her completion of supplementary certificates in diabetic foot management and thyroidology from respected medical faculties in Tunisia. Additionally, Dr. Chaima achieved significant milestones in her specialty with successful completion of the final specialty competition in Nutrition and Nutritional Diseases in September 2020 and the Hospital-University Assistant competition in October 2020. These accolades underscore her exceptional proficiency and dedication to her field, highlighting her significant contributions to medical research and practice. Her recognition reflects her ongoing commitment to excellence and her impactful role in advancing medical knowledge and patient care.

Research Skills

Dr. Jemai Chaima possesses a robust set of research skills that underscore her expertise in the field of Medicine, particularly in Nutrition and Nutritional Diseases. Her doctoral research, which earned her the highest distinction, reflects her advanced proficiency in designing and conducting complex studies. Dr. Chaima’s skills include a deep understanding of clinical research methodologies, data analysis, and evidence-based practice, essential for addressing intricate health issues related to nutrition. Her additional qualifications in diabetic foot management and thyroidology further enhance her research capabilities, providing her with a comprehensive perspective on various medical conditions. She is adept at integrating scientific knowledge with practical applications, which is crucial for developing effective interventions and treatments. Dr. Chaima’s ability to apply her research skills to real-world problems exemplifies her commitment to advancing medical science and improving patient care.

Conclusion

Jemai Chaima’s exceptional academic credentials, specialized research, and dedication to her field make her a strong candidate for the Research for Excellence in Research award. Her advanced qualifications, successful competitions, and specialized expertise in Nutrition and Nutritional Diseases underscore her significant contributions to medical research and practice. Dr. Chaima’s work exemplifies the high standards of research excellence and holds promise for continued impact in improving healthcare outcomes.

Publications Top Notes 📚
  1. Childhood obesity in Tunisia: prevalence and risk factors | Obésité chez l’enfant tunisien d’âge préscolaire: prévalence et facteurs de risque
    • Authors: M. Naifar, Y. Htira, C. Jemai, Z. H. Ali, F. B. Mami
    • Year: 2023
  2. Audit of glycemic control of diabetic patients on insulin analogues: About 2915 insured persons of the CNAM (Tunisia) | Audit de l’équilibre glycémique de patients diabétiques sous analogues de l’insuline: à propos de 2915 assurés de la CNAM (Tunisie)
    • Authors: S. Dogui, Y. Htira, C. Jemai, W. Echater, F. B. Mami
    • Year: 2022
  3. Prevalence of Cardiovascular Risk Factors in Type 1 Diabetes Mellitus Patients
    • Authors: S. Bougatf, Z. H. Ali, Y. Htira, I. Hedfi, F. B. Mami
    • Year: 2022